CIPLABSECipla LtdMediumNeutral
Announced Wed, 13 May · 13:09 IST

Outcome of board meeting on 13 May 2026

Board & Shareholder Meetings View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.9%1-day move
₹1293.70
prior close
₹1343.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.1-0.1+0.1+10.9+10.4+10.2+8.9+8.2+7.7+8.4+6.8+10.3
Up moveDown movePending
AI summary

Cipla's Board of Directors met on 13 May 2026 and approved four key items. First, the 90th Annual General Meeting is scheduled for 25 June 2026. Second, the Board granted 176,389 stock options under the ESOS 2013-A scheme (vesting in 1-2 years, exercise price INR 2) and 596,244 Employee Stock Appreciation Rights under the ESAR 2021 scheme (vesting in 1-3 years, exercise price INR 2). Third, M/s Joshi Apte & Associates was appointed as Cost Auditors for FY 2026-27. Fourth, Mr Sushrut Kulkarni was appointed as President & Global Chief – Integrated Product Development, joining the Management Council and Senior Management Personnel effective 18 May 2026. The meeting lasted from 9:45 AM to 1:00 PM.

Likely market impact

The ESOP grants and appointment of a senior R&D executive signal focus on talent retention and pipeline development. Cost auditor appointment is routine compliance. No immediate material impact on stock price expected.